Climb Bio (CLYM) Institutional Ownership $1.21 -0.03 (-2.42%) As of 05/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)CurrentInstitutional OwnershipPercentage69.76%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$41.99MNumber ofInstitutional Sellers(last 12 months)0 Get CLYM Insider Trade Alerts Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLYM Institutional Buying and Selling by Quarter Climb Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179% 5/16/2025 AQR Capital Management LLC21,808$27K0.0%N/A0.032% 5/16/2025 Allostery Investments LP244,988$299K0.4%N/A0.363% 5/16/2025 ADAR1 Capital Management LLC119,320$146K0.0%N/A0.177% 5/15/2025 RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495% 5/14/2025 Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220% 5/13/2025 Persistent Asset Partners Ltd145,760$178K0.1%N/A0.216% 5/12/2025 Nuveen LLC39,034$48K0.0%N/A0.058% 5/9/2025 Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104% 5/8/2025 XTX Topco Ltd27,660$34K0.0%N/A0.041% 5/7/2025 TD Asset Management Inc89,400$109K0.0%N/A0.132% 4/30/2025 Peapod Lane Capital LLC553,816$676K0.8%N/A0.821% 4/29/2025 Bank of New York Mellon Corp64,914$79K0.0%N/A0.096% (Data available from 1/1/2016 forward) CLYM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLYM shares? During the previous two years, 13 institutional investors and hedge funds held shares of Climb Bio. The most heavily invested institutionals were RA Capital Management L.P. ($38.33M), Affinity Asset Advisors LLC ($1.83M), Peapod Lane Capital LLC ($676K), Allostery Investments LP ($299K), Persistent Asset Partners Ltd ($178K), Goldman Sachs Group Inc. ($147K), and ADAR1 Capital Management LLC ($146K).Learn more on CLYM's institutional investors. What percentage of Climb Bio stock is owned by institutional investors? 69.76% of Climb Bio stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings. Which institutional investors have been buying Climb Bio stock? Of the 13 institutional investors that purchased Climb Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($31.42M), Affinity Asset Advisors LLC ($1.50M), Peapod Lane Capital LLC ($553.82K), Allostery Investments LP ($244.99K), Persistent Asset Partners Ltd ($145.76K), Goldman Sachs Group Inc. ($120.74K), and ADAR1 Capital Management LLC ($119.32K). How much institutional buying is happening at Climb Bio? Institutional investors have bought a total of 34,416,802 shares in the last 24 months. This purchase volume represents approximately $41.99M in transactions. Related Companies Olema Pharmaceuticals Institutional Ownership Benitec Biopharma Institutional Ownership Arcturus Therapeutics Institutional Ownership DBV Technologies Institutional Ownership Entrada Therapeutics Institutional Ownership iTeos Therapeutics Institutional Ownership Humacyte Institutional Ownership Immutep Institutional Ownership Heron Therapeutics Institutional Ownership Compass Therapeutics Institutional Ownership This page (NASDAQ:CLYM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
